Liewei Wang

15.6k citations
251 papers · 12k · 3 hit papers · h-index 57

Impact in

Papers in

    • Pharmacogenetics and Drug Metabolism 70
    • Treatment of Major Depression 21
    • Genetic Associations and Epidemiology 37
    • Estrogen and related hormone effects 23
    • BRCA gene mutations in cancer 11

Liewei Wang

249 papers receiving 11.7k citations

Liewei Wang's Hit Papers

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention 2020 · 308 citations
3080+5+10Years since publication100200300400

Peers

Liewei Wang
Comparison fields: 5 of 155
  • Pharmacology 2.4k
  • Cancer Research 1.3k
  • Oncology 1.3k
  • Molecular Biology 3.5k
  • Health Informatics 116
Replace Lang Li with:
Lang Li United States
Scott Arthur Waldman United States
Taisei Mushiroda Japan
Eric D. Wieben United States
Krishna R. Kalari United States
Koichi Matsuda Japan
Baitang Ning United States
Gregory D. Jenkins United States
Jimmie B. Vaught United States
Naoyuki Kamatani Japan
Liewei Wang relative to Lang Li United States Lang Li's profile →
Citations per field
00.5×1.6×
Lang Li · 1×
Citations per year

Countries citing papers authored by Liewei Wang

Since Specialization
Citations

This map shows the geographic impact of Liewei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liewei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liewei Wang more than expected).

Fields of papers citing papers by Liewei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liewei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liewei Wang. The network helps show where Liewei Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Liewei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Liewei Wang Line = papers co-authored together Liewei Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 251 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2009607
2
Genomics and Drug Response
Hit paper breakdown →
2011489
3 2011342
4
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention
Hit paper breakdown →
2020308
5 1999305
6 2017284
7
Preemptive Genotyping for Personalized Medicine: Design of the Right Drug, Right Dose, Right Time—Using Genomic Data to Individualize Treatment Protocol
Hit paper breakdown →
2014264
8 2004244
9 2016182
10 2006179
11 2017178
12 2010173
13 2019171
14 2005167
15 2018156
16 2017150
17 2008147
18 2017144
19 2012142
20 2019141

About Liewei Wang

Liewei Wang is a scholar working on Pharmacology, Genetics, Cancer Research, Molecular Biology and Pharmacology, having authored 251 papers that have together received 12k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (70 papers), Genetic Associations and Epidemiology (37 papers), Breast Cancer Treatment Studies (30 papers), Estrogen and related hormone effects (23 papers), Treatment of Major Depression (21 papers), Prostate Cancer Treatment and Research (16 papers), Bioinformatics and Genomic Networks (14 papers) and BRCA gene mutations in cancer (11 papers). The work is most often cited by research in Pharmacology (2.4k citations), Cancer Research (1.3k citations), Oncology (1.3k citations), Molecular Biology (3.5k citations) and Health Informatics (116 citations). Liewei Wang has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Richard M. Weinshilboum, Krishna R. Kalari, Zhenkun Lou, Gregory D. Jenkins, Brooke L. Fridley, Howard L. McLeod, Huadong Pei, Nifang Niu, Liang Li and Jia Yu. Their work appears in journals such as Pharmacogenetics and Genomics, Clinical Cancer Research, Cancer Research, PLoS ONE and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact